New diabetes clinical trial: Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Published on: April 10, 2019 at 07:00PM
Conditions:   Type2 Diabetes;   Non-Alcoholic Fatty Liver Disease
Interventions:   Drug: Evogliptin;   Drug: Pioglitazone
Sponsor:   Dong-A ST Co., Ltd.
Not yet recruiting